Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000038800 | SCV000062478 | likely benign | not specified | 2012-02-07 | criteria provided, single submitter | clinical testing | Ala524Ala in exon 12 of VCL: This variant is not expected to have clinical signi ficance because it does not alter an amino acid residue, is not located within t he splice consensus sequence, and has been identified in 0.1% (5/3738) of Africa n American chromosomes by the NHLBI Exome Sequencing Project in a broad populati on (http://evs.gs.washington.edu/EVS; dbSNP rs138566234). Ala524Ala in exon 12 of VCL (rs138566234; allele frequency = 0.1%, 5/3738) ** |
Gene |
RCV001529777 | SCV000515244 | likely benign | not provided | 2020-09-17 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24503780) |
Invitae | RCV000547966 | SCV000645843 | benign | Dilated cardiomyopathy 1W | 2024-01-31 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001529777 | SCV002048201 | benign | not provided | 2021-04-06 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000038800 | SCV002548472 | benign | not specified | 2022-05-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002390163 | SCV002703567 | likely benign | Cardiovascular phenotype | 2016-06-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002496621 | SCV002811254 | likely benign | Dilated cardiomyopathy 1W; Hypertrophic cardiomyopathy 15 | 2021-08-09 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003914953 | SCV004746087 | likely benign | VCL-related disorder | 2019-02-20 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Diagnostic Laboratory, |
RCV001529777 | SCV001743840 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000038800 | SCV001921273 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001529777 | SCV001974245 | likely benign | not provided | no assertion criteria provided | clinical testing |